Information Provided By:
Fly News Breaks for November 8, 2019
Nov 8, 2019 | 07:14 EDT
Cantor Fitzgerald analyst Alethia Young lowered her price target for Puma Biotechnology to $14 from $20 saying she's more cautious on the long-term revenue outlook for Nerlynx following the company's Q3 results. The analyst reiterates a Neutral rating on the shares.
News For PBYI From the Last 2 Days
There are no results for your query PBYI